Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Woodville South
Clinical trial register · Australia

Clinical Trials in Woodville South, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Woodville South

42 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
ResMed
Observational
90
Adelaide, Woodville South, Perth, Heidelberg
2026-09
Recruiting
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Concord, North Ryde, Woodville South, Clayton, Epping, Frankston
2026-09
Recruiting
Incyte Corporation
Phase 3
588
Macquarie Park, Chermside, Townsville, Woodville South, Melbourne, Richmond, Canberra, Perth
2026-04-09
Recruiting
IDEAYA Biosciences
Phase 3
520
Greenslopes, Woodville South, Melbourne, Westmead
2026-01-25
Recruiting
Pfizer
Phase 3
800
Buderim, Woodville South, Hobart, Clayton, Melbourne
2025-12-11
Recruiting
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
NCT07244705Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC), Immunotherapy
Anbogen Therapeutics, Inc.
Phase 1/2
66
Liverpool, Macquarie Park, Randwick, Greenslopes, Woodville South, Clayton, Heidelberg, Nedlands
2025-11
Recruiting
Amgen
Phase 1
434
Camperdown, Woodville South, Melbourne
2025-07-31
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
Exelixis
Phase 2/3
440
Clayton, Herston, Melbourne, Murdoch, St Leonards, Woodville South
2025-07-21
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
NCT06951217Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.
Phase 2
340
Camperdown, Macquarie Park, Westmead, Brisbane, Woodville South, Melbourne, Chermside, Footscray
2025-04-17
Recruiting
AstraZeneca
Phase 3
990
Coffs Harbour, Frankston, Garran, Nedlands, New Lambton, Spearwood, Wollongong, Woodville South
2025-03-25
Recruiting
AstraZeneca
Phase 2
80
East Melbourne, Wollongong, Woodville South
2025-03-12
Active, closed
Takeda
Phase 3
601
Camperdown, Westmead, Sippy Downs, Woodville South, Palmyra Dc, Victoria Park
2025-03-10
Recruiting
Amgen
Phase 3
844
Woodville South
2025-02-25
Active, closed
argenx
Phase 3
631
Sydney, Woodville South, Clayton, Murdoch
2025-01-15
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
48
Woodville South
2024-08-31
Recruiting
Amgen
Phase 3
450
Camperdown, Toowoomba, Woolloongabba, Bedford Park, Woodville South, Heidelberg
2024-07-17
Active, closed
Amgen
Phase 1
120
Camperdown, St Leonards, Woodville South, Heidelberg, Melbourne, St Albans
2024-05-29
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
NCT06343402Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC, KRAS G12C
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
350
Darlinghurst, Bedford Park, Woodville South, Frankston, Melbourne, Nedlands
2024-05-22
Active, closed
Amgen
Phase 3
434
Woodville South
2024-04-08
Active, closed
AbbVie
Phase 2
156
Bankstown, Elizabeth Vale, Woodville South, Fitzroy Melbourne, Murdoch
2024-03-23
Active, closed
AbbVie
Observational
1,200
Blacktown, Macquarie University, South Brisbane, Kurralta Park, Woodville South, Clayton, Melbourne
2024-02-19
Active, closed
Pfizer
Phase 3
1,571
Phillip, Kogarah, St Leonards, Woolloongabba, Campbelltown, Woodville South, East Melbourne, Melbourne
2023-11-08
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Maroochydore, Woodville South, Hobart
2023-10-27
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
GlaxoSmithKline
Phase 2/3
300
Camperdown, Liverpool, Adelaide, Woodville South, Fitzroy
2023-09-13
Active, closed
Bristol-Myers Squibb
Phase 3
774
Woodville South
2023-09-11
Recruiting
DynamiCure Biotechnology
Phase 1
320
Randwick, Sydney, Buderim, Bedford Park, Woodville South, Clayton, Malvern, Nedlands
2023-06-28
Active, closed
Monash University
Observational
130
Kingswood, Waratah, Bundaberg, Hervey Bay, Ipswich, Toowoomba, Woodville South, Clayton
2022-11-07
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Adelaide, Camperdown, Clayton, Herston, Murdoch, Parkville, South Brisbane, Woodville South
2022-09-13
Active, closed
Exelixis
Phase 3
901
Albury, Bankstown, Bedford Park, Heidelberg, Melbourne, Port Macquarie, Woodville South
2022-09-07
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Maroochydore, Woodville South, Hobart
2022-08-04
Active, closed
IO Biotech
Phase 3
407
Albury, Westmead, Wollongong, Cairns, Bedford Park, Woodville South, Birtinya, Melbourne
2022-05-17
Active, closed
Daiichi Sankyo
Phase 3
740
Heidelberg, Mount Waverley, Camperdown, Woodville South
2022-03-04
Recruiting
Takeda
Phase 2
135
Concord, Tweed Heads, Woodville South, Fitzroy, Melbourne, Wendouree
2021-12-16
Active, closed
Bristol-Myers Squibb
Phase 3
338
Botany, Parramatta, Maroochydore, Woodville South, Camberwell, Geelong, Ivanhoe
2021-09-15
Active, closed
Pfizer
Phase 3
599
Camperdown, Wollongong, Brisbane, Southport, Woodville South, East Melbourne, Malvern, Richmond
2021-05-12
Active, closed
Study to Evaluate D-1553 in Subjects With Solid Tumors
NCT04585035Solid Tumor, Adult, NSCLC, CRC
DrugD-1553
InventisBio Co., Ltd
Phase 1/2
180
Blacktown, East Albury, Kogarah, Waratah, Woodville South, Fitzroy, Frankston, Malvern
2020-10-02
Active, closed
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
NCT04185883Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
Amgen
Phase 1
610
Kingswood, St Leonards, South Brisbane, Woodville South, Subiaco
2019-12-17
Rows per page Showing 1–42 of 42
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/woodville-south

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 42 of those studies with a site in Woodville South.

How many clinical trials are recruiting in Woodville South?

19 of the 42 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 22 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Woodville South), 42 studies
PhaseStudiesRecruitingShare
Phase 321750%
Phase 16314.3%
Phase 25411.9%
Phase 1/2429.5%
Observational307.1%
Phase 2/3337.1%

Most active sponsors

Lead sponsors with the most studies (Woodville South)
Lead sponsorStudiesRecruiting
Amgen73
AbbVie52
AstraZeneca33
Pfizer31
Bristol-Myers Squibb20
Exelixis21
Novartis Pharmaceuticals20
Takeda21
Anbogen Therapeutics, Inc.11
argenx10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.